Monday, August 27, 2018

Rakuten Aspyrian Finds $150M For Cancer Treatments

San Diego-based biotechnology developer Rakuten Aspyrian announced last week that it has raised $150M for its efforts to develop treatments for head and neck cancer. According to Rakuten Aspyrian, the Series C funding round was led by Hiroshi Mikitani, the CEO of Japan's Rakuten. The company has now raised $238M in total funding. Mikitani also was t

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.